Group 1 - Solventum Corporation (SOLV) successfully sold its purification and filtration business to Thermo Fisher Scientific Inc. (TMO) for $4.1 billion [1] - The transaction is viewed as a significant achievement for Solventum Corporation, indicating strong corporate performance and strategic capital allocation [1] - The investing group "Value In Corporate Events" focuses on identifying opportunities in major corporate events such as IPOs, mergers & acquisitions, and earnings reports [1]